SeLux Diagnostics
Selux Diagnostics is a Boston-based company dedicated to developing precision diagnostics for infectious diseases. Their mission is to deliver personalized diagnostic information to optimize treatment, combat antibiotic-resistant superbugs, and preserve the lifesaving power of antibiotics. They focus on rapid antimicrobial susceptibility testing (AST) using their proprietary Next Generation Phenotyping (NGP) System to improve patient care and address the global health crisis of antimicrobial resistance.
Industries
Nr. of Employees
medium (51-250)
SeLux Diagnostics
Charlestown, Massachusetts, United States, North America
Products
Next-generation phenotyping (NGP) AST system
Integrated diagnostic platform for rapid phenotypic antimicrobial susceptibility testing that includes automated sample preparation, high-density assay panels, and a high-throughput analyzer to provide same-shift results from isolates and positive blood cultures.
Next-generation phenotyping (NGP) AST system
Integrated diagnostic platform for rapid phenotypic antimicrobial susceptibility testing that includes automated sample preparation, high-density assay panels, and a high-throughput analyzer to provide same-shift results from isolates and positive blood cultures.
Services
Clinical education and stakeholder engagement
Webinars, conference presentations, and educational material focused on rapid AST, breakpoint updates, and antimicrobial stewardship.
Customer support and technical assistance
Online customer hub, technical help email, and support resources for instrument and assay users.
Assay validation and breakpoint update support
Guidance and data to help laboratories validate assays and implement current clinical breakpoints.
Clinical education and stakeholder engagement
Webinars, conference presentations, and educational material focused on rapid AST, breakpoint updates, and antimicrobial stewardship.
Customer support and technical assistance
Online customer hub, technical help email, and support resources for instrument and assay users.
Assay validation and breakpoint update support
Guidance and data to help laboratories validate assays and implement current clinical breakpoints.
Expertise Areas
- Rapid antimicrobial susceptibility testing
- Direct-from-blood-culture diagnostic workflows
- Assay development and analytical methods for AST
- Clinical and multi-site performance validation
Key Technologies
- Rapid phenotypic AST
- Direct-from-positive-blood-culture testing
- 384-well high-density assay panels
- Viability assays